Blog Topic: Cancer
How Lung Tumors Hijack Nerves to Dodge the Immune System
In this blog, we discuss a recent paper by Wei et al. (2026), which uncovered a new mechanism by which tumor cells use the nervous system to bolster their position in the body.
- May 29, 2026
- 4 min read
- Chloe Fenton, PhD
Let Sleeping Cells Lie: How Immune Cells Influence Metastatic Dormancy
In this blog, we discuss how flow cytometry was used to examine metastatic dormancy, revealing a new role for immune cells in regulating this process.
- Mar 25, 2026
- 4 min read
- Chloe Fenton, PhD
ADP-Ribosylation — A PARful Regulator of the Cell
In this blog, we explore the intricate role of ADP-ribosylation in health and disease.
- Nov 27, 2025
- 4 min read
- Chloe Fenton, PhD
Cell Cannibalism: An Appetite for Cancer?
For this Halloween blog, we’re taking a taste of something slightly different: cell cannibalism.
- Oct 24, 2025
- 3 min read
- Chloe Fenton, PhD
CAR T-Cell Therapy — Driving the Future of Cancer Treatment
In this blog, we discuss a recent study that used CAR T-cell therapy in a subset of gastric cancer patients
- Sep 16, 2025
- 3 min read
- Sindhu Nair, PhD
The Role of Regulatory T Cells in the Fight against Lung Cancer
In this blog, we discuss a recent paper studying the effect of depleting Tregs in lung cancer treatment.
- Apr 23, 2025
- 5 min read
- Bio-Rad
Bispecific Antibodies: A New-Age Cancer Immunotherapy to Battle Solid Tumors
In this blog, we discuss how bsAbs are gaining traction as a novel treatment strategy for NSCLC and showing great promise in combination therapy in clinical trials.
- Feb 21, 2025
- 4 min read
- Bio-Rad
Could Salmonella Be Our Unlikely Ally in the Fight against Cancer?
In this blog, we discuss recent advances in bacterial cancer therapy (BCT).
- Jan 31, 2025
- 4 min read
- Chloe Fenton, PhD
Tumor Patrol: Dendritic Cells in Anti-Tumor Immunity
In this blog, we discuss new insights about how DCs control immune responses in the tumor microenvironment and the implications for immunotherapy.
- Aug 27, 2024
- 4 min read
- Sindhu Nair, PhD
Tipping the Balance: Could ILCs Be Used for Cancer Immunotherapy?
In this blog, we discuss the role of innate lymphoid cells (ILCs) in cancer and their potential as therapeutic targets.
- Jul 12, 2024
- 5 min read
- Chloe Fenton, PhD
Tiny Gut Microbes Boost the Immune System to Fight against Cancer
In this blog, we will delve into how the microorganisms residing in our intestines can impact the anti-tumor response triggered by immune checkpoint blockade therapy.
- Apr 08, 2024
- 4 min read
- Tyron Chang, PhD
Good TIMEs: Using the Tumor Microenvironment to Predict Response to Treatment
In this blog, we discuss a recent study by Misetic et al. (2023) in which they investigated the mechanisms behind the immune-regulatory role of the TIME and how components of the TIME could be used as biomarkers to predict response to immunotherapy.
- Mar 21, 2024
- 4 min read
- Chloe Fenton, PhD
Monoclonal Antibodies for the Treatment of Endometrial Cancer
In this blog, we discuss the recent approval of dostarlimab (Jemperli), a PD-1 inhibitor, in combination with chemotherapy as a first-line treatment for endometrial cancer.
- Feb 27, 2024
- 4 min read
- Chloe Fenton, PhD
Can Exercise Boost Anticancer Immunity?
In this blog, we discuss some of the research investigating the beneficial effects of exercise on anticancer immunity.
- Jan 04, 2024
- 5 min read
- Chloe Fenton, PhD
Spot the Difference: Why There Are Two Ways to Develop Melanoma
This blog discusses how both UV radiation and non-UV pathways can promote melanoma.
- Jul 07, 2023
- 5 min read
- Katie Lee
It Takes a Village: How a Dysfunctional Cellular Community Could Raise a Melanoma
2022 Bio-Rad Science Writing Competition winning article. Katie Lee uses an “it takes a village” analogy to explain how it is the combination of multiple factors that tips the balance toward melanoma formation.
- Feb 08, 2023
- 5 min read
- Katie Lee
350+ Ways pRB is More than Just E2F Regulation
In this guest blog, Sabine Hahn, a researcher who focuses on the dynamic regulation of chromatin structure and how that influences chromosome segregation during mitosis, discusses pRB’s vital role in cancer epigenetics.
- Feb 24, 2022
- 5 min read
- Sabine Hahn
The Cancer-Therapy Arms Race
In this guest blog, Grace Gregory discusses Non-small Cell Lung Cancer (NSCLC), some of the different treatment approaches being used, and why finding the most appropriate treatment for NSCLC isn’t always straightforward
- Feb 03, 2022
- 5 min read
- Grace Gregory, PhD
The Buzz Around STING Agonists
This blog gives an overview of the history of the STimulator of Interferon Genes (STING) pathway and highlights why pharmaceutical companies are making a beeline to develop STING agonists.
- Jun 10, 2021
- 4 min read
- Kimberley Bryon-Dodd, PhD
A Balancing AKT: the E17K Hotspot Mutation and How It Defines Cancer
AKT is an extremely important kinase in human health, playing an intricate role in coordinating fundamental signaling pathways. This blog discusses a “hotspot” mutation, called E17K, that can cause constant AKT activation and wreak havoc on cell homeostasis.
- Apr 27, 2021
- 4 min read
- Katie Roberts, PhD
Slash the Tires Instead to Slow Down Prostate Cancer
This article was awarded 3rd place in the 2020 Bio-Rad Science Writing Competition.
- Aug 19, 2020
- 4 min read
- Varadha Balaji Venkadakrishnan
The Importance of Phosphorylation Events in Cancer
This blog discusses phosphorylation, a common regulator of signal transduction pathways and the role of inappropriate phosphorylation events in cancer.
- Oct 11, 2019
- 4 min read
- Kimberley Bryon-Dodd, PhD
Can Medicine Trust Your Gut Organoids?
This blog focuses on gastrointestinal organoids and their role in advancing cancer research and therapy.
- Sep 17, 2018
- 4 min read
- Kimberley Bryon-Dodd, PhD
Checkmate: Beating Cancer through the PD-1 Pathway
This blog discusses the PD-1 (programmed cell death-1) pathway and two licensed immunotherapy drugs that target it, pembrolizumab and nivolumab.
- Jun 19, 2018
- 3 min read
- Kimberley Bryon-Dodd, PhD
When ubiquitination goes bad, knock it out for effective cancer therapy
This blog post highlights the key ubiquitin E3 ligases currently considered molecular drug targets.
- Jul 08, 2016
- 5 min read
- Annalise Barnette, PhD
Inducing macrophages that work against rather than for cancer
Within the immune response to cancer macrophages present both a problem and solution. This post describes how they can assist with tumor clearance.
- Apr 15, 2016
- 2 min read
- Annalise Barnette, PhD
GATA transcription factors and their role in cancer diagnosis and prognosis
The GATA family of transcription factors is emerging as key players in establishing new biomarkers for rapid and accurate detection of cancer. Find out more...
- Feb 15, 2016
- 3 min read
- Annalise Barnette, PhD
Inheriting mutant tumor suppressor genes increases your risk for cancer
This post describes how mutations in proto-oncogenes and tumor suppressor genes account for tumorigenesis.
- Jul 29, 2015
- 2 min read
- Bio-Rad